By using small RNA sequencing, Blume found that long non-coding RNAs (lncRNAs) nuclear enriched abundant transcript 1 (NEAT1) and long intergenic non-coding RNA p21 (lincRNA-p21) are p53 targets in CLL when cells respond to DNA damage. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.